As of 2026-03-31, 广州医药/广药集团's data on the DeepSeek platform in the 制药企业 category shows: The overall mention rate is 0.00%, below the industry average by 22.3 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 6 competitors in the same category, 广州医药/广药集团's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
广州医药/广药集团's Mention Rate is 0.00%, lower than 0.6% of competitors
广州医药/广药集团's First Mention is 0.00%, lower than 0.9% of competitors
广州医药/广药集团's Preferred Rate is 0.00%, lower than 100.0% of competitors
广州医药/广药集团's Positive Rate is 0.00%, lower than 8.9% of competitors
广州医药/广药集团's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 礼礼来 | 62.16% | 27.03% | 50% | 56.76% | 5.41% | View Details |
| 诺诺和诺德 | 62.16% | 8.11% | 0% | 45.95% | 21.62% | View Details |
| 罗罗氏 | 45.95% | 10.81% | 30% | 43.24% | 8.11% | View Details |
| 强强生 | 29.73% | 10.81% | 0% | 27.03% | 10.81% | View Details |
| 同同仁堂 | 24.32% | 0% | 0% | 10.81% | 18.92% | View Details |
| 华华润三九 | 18.92% | 10.81% | 0% | 18.92% | 0% | View Details |
| 广广州医药/广药集团 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
